Analysis of data collected in the European Society for Blood and Marrow Transplantation (EBMT) Registry on a cohort of lymphoma patients receiving plerixafor

Plerixafor + granulocyte-colony stimulating factor (G-CSF) is administered to patients with lymphoma who are poor mobilizers of hematopoietic stem cells (HSCs) in Europe. This international, multicenter, non-interventional registry study (NCT01362972) evaluated long-term follow-up of patients with l...

Descripción completa

Detalles Bibliográficos
Autores principales: Sureda, Anna, Chabannon, Christian, Masszi, Tamás, Pohlreich, David, Scheid, Christof, Thieblemont, Catherine, Wahlin, Björn E., Sakellari, Ioanna, Russell, Nigel, Janikova, Andrea, Dabrowska-Iwanicka, Anna, Touzeau, Cyrille, Esquirol, Albert, Jantunen, Esa, van der Werf, Steffie, Bosman, Paul, Boumendil, Ariane, Liu, Qianying, Celanovic, Marina, Montoto, Silvia, Dreger, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7051902/
https://www.ncbi.nlm.nih.gov/pubmed/31570781
http://dx.doi.org/10.1038/s41409-019-0693-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7051902/
https://www.ncbi.nlm.nih.gov/pubmed/31570781
http://dx.doi.org/10.1038/s41409-019-0693-z

Ejemplares similares